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Abstract
In statistical genomics, bioinformatics, and neuroinformatics, truth values of mul-
tiple hypotheses are often modeled as random quantities of a common mixture dis-
tribution in order to estimate false discovery rates (FDRs) and local FDRs (LFDRs).
Unfortunately, the FDRs or LFDRs are typically reported with conventional confidence
intervals or point estimates of a parameter of interest rather than shrunken interval and
point estimates consonant with the hierarchical model that underlies LFDR estimation.
In a pure Bayesian approach, the shrunken estimates may be derived from a fully speci-
fied prior on the parameter of interest. While such a prior may in principle be estimated
under the empirical Bayes framework, published methods taking that approach require
strong parametric assumptions about the parameter distribution.
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The proposed approach instead extends the confidence posterior distribution to the
semi-parametric empirical Bayes setting. Whereas the Bayesian posterior is defined
in terms of a prior distribution conditional on the observed data, the confidence pos-
terior is defined such that the probability that the parameter value lies in any fixed
subset of parameter space, given the observed data, is equal to the coverage rate of the
corresponding confidence interval. A confidence posterior that has correct frequentist
coverage at each fixed parameter value is combined with the estimated LFDR to yield a
parameter distribution from which interval and point estimates are derived within the
framework of minimizing expected loss. The point estimates exhibit suitable shrinkage
toward the null hypothesis value, making them practical for automatically ranking fea-
tures in order of priority. The corresponding confidence intervals are also shrunken and
tend to be much shorter than their fixed-parameter counterparts, as illustrated with
gene expression data. Further, simulations confirm a theoretical argument that the
shrunken confidence intervals cover the parameter at a higher-than-nominal frequency.
Keywords: confidence distribution; empirical Bayes; high-dimensional biology; large-scale
inference; local false discovery rate; multiple comparison procedure; multiple testing; predic-
tive distribution; random effects model
1 Introduction
By enabling simultaneous tests of whether each of thousands of genes represented on a mi-
croarray is differentially expressed across experimental or clinical conditions, advances in
biotechnology have lead to increased use of the false discovery rate (FDR) as a solution to
extreme multiple comparisons problems. As a result, the statistical community has devel-
oped more general and more powerful methods of controlling what Benjamini and Hochberg
(1995) called the FDR while proposing new definitions of the FDR (Farcomeni, 2008). The
alternative strategy of estimating rather than controlling the FDR in turn led Efron et al.
(2001) to propose estimating the local false discovery rate (LFDR), a limiting case of an FDR.
Recently, Yanofsky and Bickel (2010) found LFDR estimators to perform well in terms of
prediction error computed with gene expression microarray data, and Schwartzman et al.
(2009) applied LFDR methods to the analysis of neuroimaging data. (The terminology here
follows the empirical Bayes convention of referring to predictors of random quantities such
as the LFDR as estimators.)
FDR estimation begins with the reduction of the data directly bearing on each null
hypothesis to a low-dimensional statistic such as a Student t statistic or a p-value and the
specification of a subset of reduced-data space called the rejection region. In a general
empirical Bayes framework, the Bayesian FDR (BFDR) is the conditional probability that
a null hypothesis is true given that it is rejected, that is, given that its statistic lies in
the rejection region (Efron and Tibshirani, 2002). Relaxing the requirement that all null
hypotheses share the same rejection region and instead setting the rejection region of each
null hypothesis to the set containing only the observed value of its statistic generates a
different BFDR for each hypothesis; such a BFDR is called an LFDR. The LFDR of a null
hypothesis is the conditional probability that it is true given that its statistic is equal to
its observed value. Thus, estimates of the LFDR are often interpreted as approximations of
fully Bayesian posterior probabilities that could have been computed were a suitable joint
prior distribution of all unknown parameters available.
However, from a hierarchical Bayesian perspective, the LFDR estimate suffers as an ap-
proximation of a hypothesis posterior probability in its failure to incorporate the uncertainty
in the parameters. Similarly, from a frequentist perspective, the point estimate of the LFDR
would seem less desirable than an interval estimate of the LFDR since the latter would
reflect uncertainty in the true value of the LFDR, and correlations between data of differ-
ent biological features can introduce substantial variability into FDR and LFDR estimates
(Bickel, 2004; Qiu et al., 2005). Efron (2010) addressed the problem of estimate accuracy
by providing asymptotic bounds on the confidence limits of the FDR in the presence of
correlation between statistics. Nonetheless, it is not clear how reporting a standard error
or confidence interval for the LFDR of each of thousands of null hypotheses would facilitate
the interpretation of the results (Westfall, 2010).
Fortuitously, as the probability of hypothesis truth, the LFDR itself is of much less direct
biological interest than is the random parameter about which a hypothesis is formulated.
Both the Bayesian and frequentist criticisms that LFDR estimation inadequately incorpo-
rates uncertainty in the parameter distribution may be answered by constructing conservative
confidence intervals for the random parameters of interest under the finite mixture model
that underlies LFDR estimation, as Ghosh (2009) accomplished for a mixture of two normal
distributions.
The assumption of a known parametric model for the random parameter will be dropped
in Section 2, which instead uses a confidence posterior, a continuous distribution of confidence
levels for a given hypothesis on the basis of nested confidence intervals. Like the Bayesian
posterior, the confidence posterior is an inferential (non-physical) distribution of the pa-
rameter of interest that is coherent according to various decision theories (Bickel, 2010a,b).
Unlike the Bayesian posterior, the confidence posterior does not require specification of or
even compatibility with any prior distribution. The interest parameter θ is a subparameter
of the full parameter ξ, which specifies the sampling probability distribution Pξ. In the case
of a one-dimensional parameter of interest, the confidence posterior is completely specified
by a set of nested confidence intervals with exact coverage rates. Given the observed realiza-
tion x of a Pξ-distributed data vector X, the confidence posterior distribution P x is defined
such that the probability that the parameter lies in a given interval [θ′, θ′′] is equal to the
coverage rate of the confidence interval equal to that given interval. That is,
P x (ϑ ∈ [θ′, θ′′]) = Pξ (θ ∈ Θρ (X)) = ρ, (1)
where ϑ is the random interest parameter of distribution P x, and Θρ is the interval estimator
with rate ρ of coverage constrained such that Θρ (x) = [θ′, θ′′]. To distinguish P x (ϑ ∈ [θ′, θ′′])
for a specified hypothesis that θ ∈ [θ′, θ′′] from a confidence interval of a specified confidence
level ρ, Polansky (2007) called the former an observed confidence level. Marginalizing the
confidence posterior over the estimated LFDR as the probability of null hypothesis truth
shrinks the confidence posterior toward the parameter value of the null hypothesis. Shrunken
interval and point estimates are then derived from the marginal confidence posterior.
The use of the shrunken estimates will be illustrated in Section 3 with an application
to gene expression data. Section 4 reports a simulation study of the shrunken confidence
interval and point estimates. Section 5 closes with a summary of the findings.
2 Frequentist posteriors for shrunken estimates
2.1 Confidence posterior distributions
Considering the observed data vector x ∈ X n as a sample from a distribution in the paramet-
ric family {Pξ : ξ ∈ Ξ} parameterized by ξ in Ξ ⊆ Rd, the value in Θ ⊆ R1 of the parameter
of interest is denoted by θ (ξ). The function F• : X n × Θ → [0, 1] is called a significance
function if FX (θ) is distributed uniformly between 0 and 1 for all θ ∈ Θ and if Fx is a
cumulative distribution function for all x ∈ X n. Due to the latter property, the significance
function evaluated at x is also known as the confidence distribution (Fraser, 1991; Singh
et al., 2005), but Efron (1993) and Schweder and Hjort (2002) used that term in the sense
of the following probability distribution. Given any x ∈ X n, the confidence posterior P x is
the probability measure on measurable space (Θ,B (Θ)) of a random quantity ϑ such that
P x (ϑ ≤ θ) = Fx (θ) for all θ ∈ Θ, where each B (Θ) is the Borel σ-field on Θ. It is easy
to verify that equation (1) holds for all ξ ∈ Ξ and θ′, θ′′ ∈ Θ and for any X n-measurable
function Θ1−α1−α2 that satisfies
Θ1−α1−α2 (x) =
[
F−1x (α1) , F
−1
x (1− α2)
]
for every x ∈ X n and every α1 and α2 in [0, 1] such that α1 + α2 < 1.
As a Kolmogorov probability measure on parameter space, the confidence posterior yields
coherent decisions in the sense of minimizing expected loss, as does the Bayesian posterior,
and yet without dependence on any prior distribution (Bickel, 2010a,b). For example, the
confidence posterior mean, minimizing expected squared error loss, is ϑ¯x =
∫
Θ
ϑdP x (ϑ), and
the confidence posterior p-quantile, minimizing expected loss for a threshold-based function
of p (Carlin and Louis, 2009, App. B), is ϑ (p) such that p = P x (ϑ < ϑ (p)) .
Example 1. Assume that Yj, the observable, log-transformed difference in levels of expres-
sion of a particular gene between the jth individual of the treatment group and the jth
individual of the control group, is a normally distributed random variable of unknown mean
θ and unknown variance σ2. For the observed differences y1, . . . , yn ∈ X = R, the n-tuple
x = 〈y1, . . . , yn〉 is thus modeled as a realization of X = 〈Y1, . . . , Yn〉 , with Yi independent
of Yj for all i 6= j. Then the one-sample t-statistic τ (X) has the Student t probability dis-
tribution of n− 1 degrees of freedom. The significance function F• and confidence posterior
P x satisfy
Fx (θ) = P
x (ϑ ≤ θ) = P〈θ,σ〉 (τ (X) ≥ τ (x)) (2)
for all θ ∈ R.
Model xi ∈ X n, the ith of m observed data vectors each corresponding to a gene or
other biological feature, as a sample of Pξi with ξi ∈ Ξ as the value of the full parameter
and θi = θ (ξi) as the value of the interest parameter. The ith null hypothesis asserts that
θi = θ0, where θ0 may be any specified value in Θ.
2.2 Empirical Bayes
Empirical Bayes estimators of the LFDR flow from variations of the following hierarchical
mixture model of a data set that has been reduced to a single scalar statistic per null
hypothesis. Examples of such statistics include test statistics, p-values, and, as in Efron
(2004), probit transformations of p-values. With an X n-measurable map τ : X n → T , the
observed statistic ti = τ (xi) associated with the null hypothesis that θi = θ0 is assumed to
be a realization of the random statistic Ti of the two-component mixture probability density
function f such that
f (t) = pi0f0 (t) + pi1f1 (t) (3)
for all t ∈ T , where pi0 ∈ [0, 1] , pi1 = pi0 − 1, and f0 and f1 are probability density functions
(PDFs) corresponding to the null and alternative hypotheses, respectively. As the unknown
PDF of the statistic conditional on the alternative hypotheses, f1 is estimated by some fˆ1.
Herein, f0 is considered the known PDF of the statistic conditional on the null hypothesis, but
it can instead be estimated if m is sufficiently large (Efron, 2004). The mixture distribution
can be equivalently specified by fA, where A is a random quantity equal to 0 with probability
pi0 and to 1 with probability pi1.
Let t = 〈t1, . . . , tm〉 and T = 〈T1, . . . , Tm〉. (Since Ti and Tj are identically distributed
for all i, j ∈ {1, . . . ,m} under the mixture model (3), the model of Section 2.1 obtains
conditionally for the random θi.) The local false discovery rate for the ith statistic is defined
as the posterior probability that the ith null hypothesis is true:
`i = LFDR (ti) = P (Ai = 0|Ti = ti) = pi0f0 (ti)
f (ti)
.
It is estimated by replacing pi0 and f1 with their estimates:
ˆ`
i =
pˆi0f0 (ti)
pˆi0f0 (t) + (1− pˆi0) fˆ1 (t)
.
2.3 Extended confidence posteriors
Marginalization over hypothesis truth leads to estimated posterior probabilities that each
parameter of interest is less than, equal to, and greater than the parameter value of the null
hypothesis. Such probabilities are coherent with each confidence posterior given the truth
of the alternative hypothesis according to the confidence-based decision theory of Bickel
(2010a) and Bickel (2010b).
Consider the probability distribution P (i) of which each P xi is a conditional probability
distribution of ϑi given θi 6= θ0, of which δθ0 , the Dirac measure at θ0, is a conditional
probability distribution of ϑi given θi = θ0, and according to which `i is the probability that
θi = θ0. That is, P (i) (Ai = 0) = `i and, for all θ ∈ Θ,
P (i) (ϑi ≤ θ|Ai = 1) = P xi (ϑi ≤ θ)
and, with the function 1S (•) respectively indicating membership and non-membership in S
by 1 and 0,
P (i) (ϑi ≤ θ|Ai = 0) = δθ0 (ϑi ≤ θ) = 1[θ0,∞) (θ) .
In the more succinct mixture notation,
ϑi ∼ P (i) = `iδθ0 + (1− `i)P xi . (4)
Since P (i) as the inferential parameter distribution follows from applying Kolmogorov prob-
ability theory to the base distributions pi•, δθ0 , and P xi , decisions made on its basis are those
that would be required by the base distributions in the framework of minimizing expected
loss with respect to a confidence posterior distribution (Bickel, 2010a,b) and, more generally,
with respect to any parameter distribution (e.g., von Neumann and Morgenstern, 1944; Sav-
age, 1954). For example, as the posterior median F−1xi (1/2) minimizes the expected absolute
loss involved in estimating θi conditional on Ai = 1, the median ϑ¯i of P (i) does so marginally.
Thus, P (i) will be called the marginal confidence posterior and P xi the conditional confidence
posterior given the truth of the alternative hypothesis. Adapting the terminology of Polan-
sky (2007) concerning fixed parameters of interest, P (i)-probabilities and P xi-probabilities of
hypotheses will be called (observed) marginal and conditional confidence levels, respectively.
Since pi• is unknown, the marginal confidence posterior will be estimated by
Pˆ (i) = ˆ`iδθ0 +
(
1− ˆ`i
)
P xi , (5)
which resembles the marginal empirical Bayes posterior from which Ghosh (2009) derived
conservative confidence intervals under a parametric model. (Efron (2008) similarly derived
empirical Bayes interval estimates conditional on Ai = 1 in order to contrast them with
estimates that control a false coverage rate (Benjamini et al., 2005).) The two posterior
distributions differ in that P xi is a confidence posterior rather than the Bayesian posterior
Pprior (•|Ai = 1, Ti = ti), which requires specification or estimation of Pprior (•|Ai = 1), a prior
distribution of θi conditional on the truth of the alternative hypothesis. For ease of reading,
Pˆ (i)-probabilities of hypotheses will be called (observed) marginal confidence levels even
though they are more precisely estimates of such levels.
Example 2. Generalizing Example 1 to multiple genes, let xi denote the n-tuple of log-
transformed differences in levels of expression of the ith of m genes. The ith null hypothesis
is that the ith gene is equivalently expressed (θi = 0) as opposed to differentially expressed
(θi 6= 0). Further, let P xi denote the corresponding confidence posterior defined by equation
(2) and the normality and conditional independence assumptions of Example 1. That P xi is
mathematically equivalent to the Bayesian posterior Pprior (•|Ai = 1, Ti = ti) formulated by
the uniform “distribution” (Lebesgue measure) as the prior for θi and integrating over the
standard deviation σ with respect to the posterior from the independent prior density pro-
portional to 1/σ. Since the prior is not a Kolmogorov probability distribution, the estimated
posterior odds given by multiplying the estimated prior odds (1− pˆi0) /pˆi0 by the Bayes factor
is undefined (Berger and Pericchi, 1996; Yanofsky and Bickel, 2010). Thus, there is no prior
distribution that corresponds to Pˆ (i) in this example. (Yanofsky and Bickel (2010) used a
predictive distribution on the basis of an intuitively motivated posterior equivalent to Pˆ (i)
to assess the performance of various predictors of gene expression data.)
2.4 Point and interval estimates
Were the marginal confidence posterior P (i) known, its mean and median would respectively
minimize expected square-error and absolute loss incurred by estimating θi (§2.1), and the
odds for betting that θi lies in some subset Θ′ of Θ would be P (i) (ϑi ∈ Θ′) /P (i) (ϑi ∈ Θ\Θ′),
a ratio of two observed marginal confidence levels (Bickel, 2010a).
Those decision-theoretic considerations suggest estimating θi by the mean or median of
Pˆ (i) and constructing the (1− α1 − α2) 100% marginal confidence interval
[
Fˆ−1(i) (α1) , Fˆ
−1
(i) (1− α2)
]
from the marginal significance function Fˆ(i) defined by Fˆ(i) (θ) = Pˆ (i) (ϑi ≤ θ) for all θ ∈ Θ.
Inverting Fˆ(i) gives, for any α ∈ [0, 1],
Fˆ−1(i) (α) =

F−1xi
(
α/
(
1− ˆ`i
))
if F−1xi
(
α/
(
1− ˆ`i
))
< θ0
F−1xi
(
1− (1− α) /
(
1− ˆ`i
))
if F−1xi
(
1− (1− α) /
(
1− ˆ`i
))
> θ0
θ0 otherwise
, (6)
where Fxi is the conditional significance function defined in Section 2.1.
While the Pˆ (i)-probability that ϑi lies in the interval estimate is exactly (1− α1 − α2) 100%
by construction, it does not have exact frequentist coverage. However, two limiting cases
suggest that the marginal confidence interval covers the random value of θi at a relative
frequency greater than the nominal rate ρ = (1− α1 − α2) 100%:
lim
λ→0
Ptrue
(
θi ≤ Fˆ−1(i) (α) |Ai = 1, ˆ`i ≤ λ
)
= Ptrue (Fxi (θi) ≤ α|Ai = 1) = α (7)
lim
λ→1
Ptrue
(
θi ≤ Fˆ−1(i) (α) |Ai = 0, ˆ`i ≥ λ
)
= Ptrue (θi = θ0|Ai = 0) = 1, (8)
where 0 < α < 1 and 0 < λ < 1; Ptrue is the sampling distribution of 〈θi, Xi〉. To the
extent that 1− pi0 is small, the actual coverage rate Ptrue
(
θi ∈
[
Fˆ−1(i) (α1) , Fˆ
−1
(i) (1− α2)
])
is
dominated by the rate conditional on Ai = 0. For that reason, equation (8) indicates that,
inasmuch as pˆi0 is a positively biased estimator of some sufficiently small pi0, the confidence
intervals derived from Pˆ (i) are conservative in the sense that they include the random value of
θi at a relative frequency higher than the nominal (1− α1 − α2) 100% level for any α1, α2 ∈
[0, 1] such that α1 + α2 < 1.
Likewise, the Pˆ (i)-posterior median Fˆ−1(i) (1/2), corresponding to the degenerate 0% con-
fidence interval
[
Fˆ−1(i) (50%) , Fˆ
−1
(i) (50%)
]
, is conservative in the sense that a positive bias in
ˆ`
i pulls the estimate Fˆ−1(i) (1/2) toward θ0. The extent of the conservatism of both point and
interval estimates was quantified by simulation as described in Section 4.
3 Application to gene expression
Microarray technology enables measurement of the expression levels of thousands of genes
for each biological replicate, an organism or set of organisms studied. Most microarray
experiments are designed to determine which genes to consider differentially expressed across
two conditions, conveniently called treatment and control. Investigators initially relied on
estimates of an average ratio of expression under the treatment condition to that under
the control condition without using hypothesis tests. As statisticians have responded with
extensive research on multiple comparison procedures, biologists have moved to ignoring
estimated levels of differential expression for all genes that do not correspond to rejected
null hypotheses.
In response, Montazeri et al. (2010) proposed the prioritization of genes for further study
by shrunken estimates of differential expression levels, much as Stromberg et al. (2008) and
Wei et al. (2010) suggested prioritizing single-nucleotide polymorphisms (SNPs) by shrunken
estimates of odds ratios. Whereas Montazeri et al. (2010), following Bickel (2008) and Yanof-
sky and Bickel (2010), used a heuristic estimate equal in value to the posterior mean with
respect to Pˆ (i), the posterior median has the advantage of invariance to reparameterization.
Since, in addition, the posterior median is a limiting case of a confidence interval (§2.4), it
will be used as the point estimate alongside the interval estimate.
While point estimation is practical for ranking genes in order of priority, interval estimates
are needed to quantify their reliability. In place of the commonly used confidence intervals
that do not account for multiple comparisons, we will report the shrunken confidence intervals
of equation (6).
The amount the gene expression differs between mutant tomatoes and wild type (WT)
tomatoes were estimated for n = 6 mutant-WT (“treatment-control”) pairs at 3 days after the
breaker stage of ripening; the microarrays represent 13,440 genes. Alba et al. (2005) provide
details of the fruit development experiments conducted. Due to the pairing of mutant and
WT biological replicates, the normal model and confidence posteriors of Examples 1 and 2
were used. Each local false discovery rate was estimated by the “theoretical null” method
of Efron (2007) since simulations indicate that the “empirical null” method applied to the
model of 1 and 2 loses power in the presence of heavy-tailed data like that of gene expression
(Bickel, 2010b).
Each circle of Fig. 1 represents a point or interval estimate of θi for a gene. The left-hand
side displays the posterior median of ϑi versus ˆ`i on the basis of each marginal confidence pos-
terior Pˆ (i) (black) and each conditional confidence posterior P xi (gray). Stronger shrinkage
is evident at higher values of ˆ`i.
The right-hand side of Fig. 1 features the width of the confidence interval from each Pˆ (i)
versus the width of the confidence interval from each P xi . It is apparent that the use of
the marginal confidence posterior in place of the conditional confidence posterior tends to
substantially reduce interval width.
In Fig. 2, observed marginal confidence levels are plotted against observed conditional
confidence levels to show how much inferential probability each attributes to the hypothesis
that θi < 0 and to the hypothesis that θi > 0. The horizontal axis has P xi (ϑi < 0), which
is equal to P (i) (ϑi < 0|Ai = 1) and to 1 − P xi (ϑi > 0). The vertical axis has Pˆ (i) (ϑi < 0)
in black and Pˆ (i) (ϑi > 0) in gray; these marginal confidence levels do not total 100% since
Pˆ (i) (ϑi = 0) = `i > 0.
4 Simulation study
Levels of gene expression and corresponding observations were simulated for 2000 gene ex-
pression experiments each with pi0 = 90% probability that any gene is equivalently, n = 2
observations per gene, and m = 104 genes, as follows. For each experiment, the mean differ-
ential expression levels θ1, . . . , θm were independently assigned 0 with probability pi0, −2 with
probability (1− pi0) /2, and +2 with probability (1− pi0) /2. Then, for each i = 1, . . . ,m,
the n observed expression levels were independently drawn from N (θi, σ2i ), where σi = 1 if
θi = 0 and σi = 3/2 if θi 6= 0, in accordance with Examples 1 and 2. The posterior medians
Fˆ−1x1 (50%) and Fˆ
−1
(1) (50%) and the 95% confidence intervals
[
F−1x1 (2.5%) , F
−1
x1
(97.5%)
]
and[
Fˆ−1(1) (2.5%) , Fˆ
−1
(1) (97.5%)
]
were computed for each simulated experiment. A total of 2000
experiments were thereby simulated and analyzed. To assess dependence on the proportion
of true null hypotheses, all of the simulations and analyses were repeated for pi0 = 99% using
the same seed of the pseudo-random numbers.
Fig. 3 consists of histograms of the posterior median errors Fˆ−1(i) (1/2) − θi (black) and
F−1xi (1/2) − θi (gray) according to each marginal confidence posterior Pˆ (i) and each condi-
tional confidence posterior P xi , respectively. The left panel corresponds to 1 − pi0 = 10%
and the right panel to 1− pi0 = 1%.
Fig. 4 gives the width of the confidence interval from each Pˆ (i) versus the width of the
confidence interval from each P xi for 1−pi0 = 10% (left) and 1−pi0 = 1% (right). Each circle
corresponds to a simulated experiment. As seen in the application to gene expression (§3),
the marginal confidence intervals tend to be much shorter than the conditional confidence
intervals.
The smaller intervals do not compromise frequentist coverage. On the contrary, the
confidence intervals from Pˆ (i) cover the simulated values of θi at rates higher than the
nominal 95% level (Table 1), in agreement with equations (7) and (8).
5 Discussion
As an extension of both a confidence posterior and an empirical Bayes posterior, Pˆ (i) offers
new approaches to two related problems in high-dimensional biology. First, the problem
of prioritizing biological features for further study was addressed by ranking the features
according to their Pˆ (i)-posterior means or medians. Since a point estimate for an individual
feature of scientific interest is difficult to interpret without an indication of its reliability,
the problem of reporting interval estimates consonant with the point estimates was handled
by constructing the confidence intervals of each feature to have the posterior median at its
center. The next two paragraphs summarize the findings relevant to each proposed solution
in turn.
The posterior median of Pˆ (i) is suitable for ranking features in order of priority or interest
since it is parameterization-invariant and since it adjusts the uncorrected parameter estimate
according to statistical significance as recorded in the LFDR. The commonly used alternative
of using the LFDR or other measure of significance to make and accept-reject decision
followed by conventional estimation of the parameter does not perform well since it depends
on an arbitrary threshold to distinguish acceptance from rejection (Montazeri et al., 2010).
The simulations show that the posterior median of Pˆ (i) does perform well in terms of hitting
or coming close to its target parameter value (Fig. 3).
The confidence intervals based on Pˆ (i) are not only centered at the estimates recom-
mended for ranking features, but also tend to be much shorter than the fixed-parameter
confidence intervals on which they are based, as seen both in the application to gene expres-
sion (Fig. 1) and in the simulation study (Fig. 4). In spite of their shortness, the shrunken
confidence intervals cover their target parameter values at rates higher than those claimed
(Table 1).
Some caution is needed in interpreting Pˆ (i) (ϑi < θ0), Pˆ (i) (ϑi = θ0), Pˆ (i) (ϑi > θ0), and
other observed marginal confidence levels as posterior probabilities for decision-making pur-
poses. Since the LFDR estimate ˆ`i is conservative in the sense that it has an upward bias
(Pawitan et al., 2005; Yang and Bickel, 2010), the Pˆ (i)-probability of any hypothesis that
includes or excludes θ0 will tend to be too high or too low, respectively. For example, there
is no warrant for concluding from Pˆ (i) (ϑi = θ0) = ˆ`i = 100% that the null hypothesis is
true with absolute certainty (Bickel, 2010b; Yang and Bickel, 2010), and the observed con-
ditional confidence of Fig. 2 and studied by Bickel (2010b) would thus perform better in
terms of logarithmic loss or other scoring rules that infinitely penalize predicting an event
with certainty that does not occur.
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1− pi0 = 10% 1− pi0 = 1%
Marginal confidence 97.5% 99.2%
Conditional confidence 95.3% 95.3%
Table 1: 95% confidence interval coverage.
